Sclerosis News and Research RSS Feed - Sclerosis News and Research

Christopher & Dana Reeve Foundation awards Quality of Life grants to 79 nonprofit organizations

Christopher & Dana Reeve Foundation awards Quality of Life grants to 79 nonprofit organizations

The Christopher & Dana Reeve Foundation, a national nonprofit dedicated to improving quality of life for individuals living with paralysis, announced it has awarded $575,704 in Quality of Life grants to 79 nonprofit organizations nationwide. [More]
People with high levels of four biomarkers may have increased risk for stroke

People with high levels of four biomarkers may have increased risk for stroke

People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Boosting levels of a specific protein in the brain alleviates hallmark features of Alzheimer's disease in a mouse model of the disorder, according to new research published online August 25, 2016 in Scientific Reports. [More]
HMS study reveals key instigator of nerve cell damage in ALS patients

HMS study reveals key instigator of nerve cell damage in ALS patients

Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder. [More]
National MS Society awards grant to investigate impact of popular diets on multiple sclerosis-related fatigue

National MS Society awards grant to investigate impact of popular diets on multiple sclerosis-related fatigue

The National Multiple Sclerosis Society has just committed over $1 million to support a clinical trial at the University of Iowa led by Terry Wahls, MD, to compare the ability of two popular diets to treat multiple sclerosis-related fatigue, a disabling symptom that can significantly interfere with a person's ability to function at home and work. [More]
Cell therapy product can accelerate brain remyelination in mice

Cell therapy product can accelerate brain remyelination in mice

Demyelinating diseases, such as multiple sclerosis and leukodystrophy, are characterized by damage to the protective myelin sheath that surrounds the axons of neurons. [More]

ECTRIMS previews important sessions ahead of world’s largest annual congress of multiple sclerosis

The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) previews the key sessions ahead of its annual congress – a dedicated platform to promote and enhance research in Multiple Sclerosis. The 32nd edition of the world’s largest congress of multiple sclerosis will take place in London from 14 – 17 September 2016. [More]
MGH investigators discover key molecules essential for sensing proteasome dysfunction

MGH investigators discover key molecules essential for sensing proteasome dysfunction

Maintaining appropriate levels of proteins within cells largely relies on a cellular component called the proteasome, which degrades unneeded or defective proteins to recycle the components for the eventual assembly of new proteins. [More]
Common gaming camera could be effective in evaluating walking difficulties of MS patients

Common gaming camera could be effective in evaluating walking difficulties of MS patients

A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients. [More]
Hygiene hypothesis: a misleading misnomer? An interview with Professor Sally Bloomfield

Hygiene hypothesis: a misleading misnomer? An interview with Professor Sally Bloomfield

Professor Strachan first proposed the hygiene hypothesis back in 1989. Reviewing the evidence, he suggested that one of the causes of the recent rapid rise in allergic diseases in children was lack of exposure to childhood infections [More]
Early treatment of multiple sclerosis may offer long-lasting effect on disease activity

Early treatment of multiple sclerosis may offer long-lasting effect on disease activity

Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the August 10, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Novel therapeutic strategy could target multiple aspects of Alzheimer's disease

Novel therapeutic strategy could target multiple aspects of Alzheimer's disease

Therapeutic strategies targeting Alzheimer's disease (AD)-related molecule β-amyloid (Aβ), Tau protein and BACE enzyme have been recently explored. However the therapeutic efficacy for a single target is not ideal. [More]
Research findings may have implications for ALS and other neurological disorders

Research findings may have implications for ALS and other neurological disorders

Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a progressive disorder that devastates motor nerve cells. People diagnosed with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe. [More]
New review finds link between sleep disorders and stroke risk

New review finds link between sleep disorders and stroke risk

There is growing evidence that sleep disorders like insomnia and sleep apnea are related to stroke risk and recovery from stroke, according to a recent literature review. [More]
MIT scientists design new microfluidic device that mimics neuromuscular junction

MIT scientists design new microfluidic device that mimics neuromuscular junction

MIT engineers have developed a microfluidic device that replicates the neuromuscular junction -- the vital connection where nerve meets muscle. [More]
Inosine treatment can help restore motor control after cortical injury

Inosine treatment can help restore motor control after cortical injury

Brain tissue can die as the result of stroke, traumatic brain injury, or neurodegenerative disease. When the affected area includes the motor cortex, impairment of the fine motor control of the hand can result. [More]
Penn's ADCC receives $8.8 million grant to continue research on treatment for AD and related dementias

Penn's ADCC receives $8.8 million grant to continue research on treatment for AD and related dementias

The University of Pennsylvania's Alzheimer's Disease Core Center has been awarded an estimated $8.8 million over five years from the National Institute on Aging to continue its mission of investigating mechanisms, diagnostics, treatments and strategies for Alzheimer's Disease (AD) and related dementias including Parkinson's disease (PD), Parkinson's disease dementia (PDD), Lewy Body dementia (LBD) and frontotemporal lobar degeneration (FTLD). [More]
New review examines potential of antioxidant therapies to combat neurodegenerative disorders

New review examines potential of antioxidant therapies to combat neurodegenerative disorders

A new review examines the potential of antioxidant approaches for the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. [More]
Scientists uncover novel sites of expression in the brain for gene linked to ALS and FTD

Scientists uncover novel sites of expression in the brain for gene linked to ALS and FTD

For the first time novel expression sites in the brain have been identified for a gene which is associated with Motor Neuron Disease and Frontotemporal Dementia. [More]
Personalized virtual brain model of epileptic patient could lead to more precise diagnosis

Personalized virtual brain model of epileptic patient could lead to more precise diagnosis

Researchers at CNRS, INSERM, Aix-Marseille University and AP-HM have just created a virtual brain that can reconstitute the brain of a person affected by epilepsy for the first time. [More]
Advertisement
Advertisement